Bill Sibold | BiotechTV

top of page

Apr 10, 2024

The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease

Bill Sibold describes how Madrigal has prepared for the launch and illustrates how the medicine is meant to impact disease progression.

Madrigal's CEO discusses the NASH field ahead of a key FDA decision date in March

Jan 9, 2024

Company News

Madrigal's CEO discusses the NASH field ahead of a key FDA decision date in March

Bill Sibold describes how resmetirom acts on fibrosis and could be the first commercial product in NASH.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Saville's Life Sciences Overview